C. Guillaume

发表

Aerosolization of cationic lipid-DNA complexes: lipoplex characterization and optimization of aerosol delivery conditions.

C. Guillaume, P. Delépine, C. Droal, 2001, Biochemical and biophysical research communications.

Efficient gene transfer into human epithelial cell lines using glycosylated cationic carriers and neutral glycosylated co-lipids.

C. Férec, C. Guillaume, P. Delépine, 2004 .

Biodistribution study of phosphonolipids: a class of non‐viral vectors efficient in mice lung‐directed gene transfer

C. Férec, C. Guillaume, P. Delépine, 2003, The journal of gene medicine.

The use of in situ hybridization to study the transgene pathway following cellular transfection with cationic phosphonolipids.

C. Férec, A. Cavalier, Daniel Thomas, 2003, Blood cells, molecules & diseases.

Transgene expression kinetics after transfection with cationic phosphonolipids in hematopoietic non adherent cells.

C. Férec, C. Guillaume, J. Yaouanc, 1998, Biochimica et biophysica acta.

Behavior of human osteoblast-like cells in contact with electrodeposited calcium phosphate coatings.

H. Benhayoune, C. Guillaume, G. Balossier, 2006, Journal of biomedical materials research. Part B, Applied biomaterials.

Impact of the Maturation of Human Primary Bone-Forming Cells on Their Behavior in Acute or Persistent Staphylococcus aureus Infection Models

C. Guillaume, S. Gangloff, F. Draux, 2016, Front. Cell. Infect. Microbiol..

Effect of strontium-substituted biphasic calcium phosphate on inflammatory mediators production by human monocytes.

J. Nedelec, C. Guillaume, P. Laquerriere, 2012, Acta biomaterialia.

A new insight into the dissociating effect of strontium on bone resorption and formation.

J. Nedelec, C. Guillaume, P. Laquerriere, 2011, Acta biomaterialia.

In vitro and in vivo evaluation of the inflammatory potential of various nanoporous hydroxyapatite biomaterials.

J. Fricain, J. Amédée, K. Anselme, 2015, Nanomedicine.

An Optimized Method to Generate Human Active Osteoclasts From Peripheral Blood Monocytes

C. Guillaume, S. Gangloff, M. Jourdain, 2018, Front. Immunol..

New biocompatible cationic amphiphiles derivative from glycine betaine: a novel family of efficient nonviral gene transfer agents.

C. Férec, C. Guillaume, T. Benvegnu, 1998, Biochemical and biophysical research communications.

Systemic administration of cationic phosphonolipids/DNA complexes and the relationship between formulation and lung transfection efficiency.

C. Férec, C. Guillaume, P. Delépine, 2000, Biochimica et biophysica acta.

Chitosan/hydroxyapatite hybrid scaffold for bone tissue engineering.

C. Guillaume, S. Gangloff, F. Draux, 2014, Bio-medical materials and engineering.

Cystic fibrosis and bone disease: defective osteoblast maturation with the F508del mutation in cystic fibrosis transmembrane conductance regulator.

L. Touqui, I. Sermet-Gaudelus, C. Guillaume, 2014, American journal of respiratory and critical care medicine.

Cystic fibrosis transmembrane conductance regulator (CFTR) regulates the production of osteoprotegerin (OPG) and prostaglandin (PG) E2 in human bone.

L. Touqui, I. Sermet-Gaudelus, C. Guillaume, 2010, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Visualization of the transgene distribution according to the administration route allows prediction of the transfection efficacy and validation of the results obtained

C. Férec, C. Guillaume, P. Delépine, 2002, Gene Therapy.

Cationic phosphonolipids as nonviral vectors: in vitro and in vivo applications.

C. Férec, C. Guillaume, P. Delépine, 2000, Journal of pharmaceutical sciences.

Phosphonocationic lipids in protein delivery to mice lungs.

C. Férec, C. Guillaume, P. Delépine, 2000, Journal of pharmaceutical sciences.

Strontium-Substituted Bioceramics Particles: A New Way to Modulate MCP-1 and Gro-α Production by Human Primary Osteoblastic Cells

J. Nedelec, C. Guillaume, S. Gangloff, 2016, Materials.

Inhibition of Recruitment and Activation of Neutrophils by Pyridazinone-Scaffold-Based Compounds

C. Guillaume, S. Gangloff, R. Tirouvanziam, 2022, International journal of molecular sciences.

Infusion of docosahexaenoic acid protects against myocardial infarction.

C. Guillaume, F. Visioli, C. Brou, 2014, Prostaglandins, leukotrienes, and essential fatty acids.

Increased internalization of Staphylococcus aureus and cytokine expression in human Wharton's jelly mesenchymal stem cells.

C. Guillaume, S. Gangloff, J. Josse, 2014, Bio-medical materials and engineering.

Pyridazinone Derivatives Limit Osteosarcoma-Cells Growth In Vitro and In Vivo

C. Guillaume, S. Gangloff, Stéphane Gérard, 2021, Cancers.

Proteolipidic vectors for gene transfer to the lung.

C. Férec, C. Guillaume, L. Vaysse, 2002, Biochemical and biophysical research communications.

Efficient gene transfer into human epithelial cell lines using glycosylated cationic carriers and neutral glycosylated co-lipids.

C. Férec, C. Guillaume, P. Delépine, 2004, Blood cells, molecules & diseases.

Human Osteoblast-Conditioned Media Can Influence Staphylococcus aureus Biofilm Formation

C. Guillaume, S. Gangloff, F. Velard, 2022, International journal of molecular sciences.

The effect of zinc on hydroxyapatite-mediated activation of human polymorphonuclear neutrophils and bone implant-associated acute inflammation.

J. Nedelec, C. Guillaume, P. Laquerriere, 2010, Biomaterials.

Polymorphonuclear neutrophil response to hydroxyapatite particles, implication in acute inflammatory reaction.

J. Nedelec, C. Guillaume, P. Laquerriere, 2009, Acta biomaterialia.

Zinc doped hydroxyapatite as immunomodulatory biomaterial

J. Nedelec, C. Guillaume, P. Laquerriere, 2009 .

Overexpression of RANKL in osteoblasts: a possible mechanism of susceptibility to bone disease in cystic fibrosis

I. Sermet-Gaudelus, C. Guillaume, S. Gangloff, 2016, The Journal of pathology.

Osteoclastogenesis and sphingosine-1-phosphate secretion from human osteoclast precursor monocytes are modulated by the cystic fibrosis transmembrane conductance regulator.

C. Guillaume, S. Gangloff, M. Jourdain, 2020, Biochimica et biophysica acta. Molecular basis of disease.

CFTR-deficient pigs display alterations of bone microarchitecture and composition at birth.

M. Si-Tahar, V. Untereiner, C. Guillaume, 2019, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Cystic fibrosis bone disease: is the CFTR corrector C18 an option for therapy?

L. Touqui, F. Le Pimpec Barthès, I. Sermet-Gaudelus, 2014, European Respiratory Journal.

Deficit of osteoprotegerin release by osteoblasts from a patient with cystic fibrosis

C. Guillaume, C. Norez, F. Becq, 2012, European Respiratory Journal.

Caecum: A Potential Site for Studying Gene Transfer in vivo

C. Férec, C. Guillaume, P. Delépine, 2000 .